Visual Abstract for this week’s (tonight’s!) #NephJC by Bea Concepcion
FIND-CKD extends finerenone beyond diabetic kidney disease, showing slower eGFR decline and sustained albuminuria reduction in non-diabetic CKD. While the benefits are modest and cardiovascular effects remain uncertain, the trial opens the door to broader use of nsMRAs and raises important questions about combination therapy with SGLT2 inhibitors.
Can rivaroxaban improve cardiovascular outcomes in patients with advanced CKD.? Although vascular inflammation and thrombosis are at the heart of CV damage, anticoagulants have not previously shown benefits in CVD patients.
This week, NephJC will discuss whether obinutuzumab is ready to outperform tacrolimus in primary membranous nephropathy
In this edition of NephJC, we discuss the largest case series of kidney biopsies in patients with Diabetes.
Visual Abstract for this week’s (tonight’s!) #NephJC by Bea Concepcion
Roopa Shah did this great visual abstract
File this under better late than never, the visual abstract for last night and tonight's #NephJC is here!
Thiazide induced hyponatremia is this week's version of spooky sodium. Here's the visual abstract.
The recent CJASN data from DOPPS, also links to two excellent videos from the NHS Heart of England centre. They are a first person account, giving a vivid example of the change that simple itching can have in all aspects of day to day life.
The Visual Abstract for the ACTIVE trial NephJC, scheduled for Tuesday/Wednesday this week. From the Visual Abstract artist, @KidneyBea_n